Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologic Therapeutics Drugs Market 2018, Forecast to 2023
Scope of the Report:
This report focuses on the Biologic Therapeutics Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The worldwide market for Biologic Therapeutics Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Biologic Therapeutics Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologic Therapeutics Drugs, with sales, revenue, and price of Biologic Therapeutics Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologic Therapeutics Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologic Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
This report focuses on the Biologic Therapeutics Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The worldwide market for Biologic Therapeutics Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Pfizer
- AstraZeneca
- Novartis
- Merck
- Smith Medical
- GlaxoSmithKline
- Concord Biotech
- Aurobindo Pharma
- H. Lundbeck
- Retractable Technologies
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Humans
- Avian Cell Culture
- Yeast
- Bacteria
- Insects Cell Culture
- Transgenics
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
Chapter 1, to describe Biologic Therapeutics Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologic Therapeutics Drugs, with sales, revenue, and price of Biologic Therapeutics Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologic Therapeutics Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologic Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Biologic Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Humans
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Market Analysis by Applications
1.3.1 Rheumatoid Arthritis
1.3.2 Anemia
1.3.3 Cancer
1.3.4 Diabetes
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Biologic Therapeutics Drugs Product Introduction
2.1.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biologic Therapeutics Drugs Product Information
2.1.3 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Biologic Therapeutics Drugs Market Share in 2017
2.2 AstraZeneca
2.2.1 Business Overview
2.2.1.1 AstraZeneca Description
2.2.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.2.2 AstraZeneca Biologic Therapeutics Drugs Product Introduction
2.2.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biologic Therapeutics Drugs Product Information
2.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global AstraZeneca Biologic Therapeutics Drugs Market Share in 2017
2.3 Novartis
2.3.1 Business Overview
2.3.1.1 Novartis Description
2.3.1.2 Novartis Headquarter, Main Business and Finance Overview
2.3.2 Novartis Biologic Therapeutics Drugs Product Introduction
2.3.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Biologic Therapeutics Drugs Product Information
2.3.3 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Novartis Biologic Therapeutics Drugs Market Share in 2017
2.4 Merck
2.4.1 Business Overview
2.4.1.1 Merck Description
2.4.1.2 Merck Headquarter, Main Business and Finance Overview
2.4.2 Merck Biologic Therapeutics Drugs Product Introduction
2.4.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Biologic Therapeutics Drugs Product Information
2.4.3 Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Merck Biologic Therapeutics Drugs Market Share in 2017
2.5 Smith Medical
2.5.1 Business Overview
2.5.1.1 Smith Medical Description
2.5.1.2 Smith Medical Headquarter, Main Business and Finance Overview
2.5.2 Smith Medical Biologic Therapeutics Drugs Product Introduction
2.5.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Biologic Therapeutics Drugs Product Information
2.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Smith Medical Biologic Therapeutics Drugs Market Share in 2017
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.1.1 GlaxoSmithKline Description
2.6.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.6.2 GlaxoSmithKline Biologic Therapeutics Drugs Product Introduction
2.6.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Biologic Therapeutics Drugs Product Information
2.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global GlaxoSmithKline Biologic Therapeutics Drugs Market Share in 2017
2.7 Concord Biotech
2.7.1 Business Overview
2.7.1.1 Concord Biotech Description
2.7.1.2 Concord Biotech Headquarter, Main Business and Finance Overview
2.7.2 Concord Biotech Biologic Therapeutics Drugs Product Introduction
2.7.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Biologic Therapeutics Drugs Product Information
2.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Concord Biotech Biologic Therapeutics Drugs Market Share in 2017
2.8 Aurobindo Pharma
2.8.1 Business Overview
2.8.1.1 Aurobindo Pharma Description
2.8.1.2 Aurobindo Pharma Headquarter, Main Business and Finance Overview
2.8.2 Aurobindo Pharma Biologic Therapeutics Drugs Product Introduction
2.8.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Biologic Therapeutics Drugs Product Information
2.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Aurobindo Pharma Biologic Therapeutics Drugs Market Share in 2017
2.9 H. Lundbeck
2.9.1 Business Overview
2.9.1.1 H. Lundbeck Description
2.9.1.2 H. Lundbeck Headquarter, Main Business and Finance Overview
2.9.2 H. Lundbeck Biologic Therapeutics Drugs Product Introduction
2.9.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Biologic Therapeutics Drugs Product Information
2.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global H. Lundbeck Biologic Therapeutics Drugs Market Share in 2017
2.10 Retractable Technologies
2.10.1 Business Overview
2.10.1.1 Retractable Technologies Description
2.10.1.2 Retractable Technologies Headquarter, Main Business and Finance Overview
2.10.2 Retractable Technologies Biologic Therapeutics Drugs Product Introduction
2.10.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Biologic Therapeutics Drugs Product Information
2.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Retractable Technologies Biologic Therapeutics Drugs Market Share in 2017
3 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Biologic Therapeutics Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Biologic Therapeutics Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Biologic Therapeutics Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Biologic Therapeutics Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Biologic Therapeutics Drugs Sales by Regions (2013-2018)
4.1.2 Global Biologic Therapeutics Drugs Revenue by Regions (2013-2018)
4.2 North America Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Biologic Therapeutics Drugs Sales by Countries (2013-2018)
5.1.2 North America Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
5.1.3 United States Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.2 North America Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
6 EUROPE BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologic Therapeutics Drugs Sales by Countries (2013-2018)
6.1.2 Europe Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologic Therapeutics Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
7.1.3 China Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Biologic Therapeutics Drugs Sales by Countries (2013-2018)
8.1.2 South America Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.2 South America Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET SEGMENT BY TYPE
10.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biologic Therapeutics Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2013-2018)
10.2 Humans Sales Growth and Price
10.2.1 Global Humans Sales Growth (2013-2018)
10.2.2 Global Humans Price (2013-2018)
10.3 Avian Cell Culture Sales Growth and Price
10.3.1 Global Avian Cell Culture Sales Growth (2013-2018)
10.3.2 Global Avian Cell Culture Price (2013-2018)
10.4 Yeast Sales Growth and Price
10.4.1 Global Yeast Sales Growth (2013-2018)
10.4.2 Global Yeast Price (2013-2018)
10.5 Bacteria Sales Growth and Price
10.5.1 Global Bacteria Sales Growth (2013-2018)
10.5.2 Global Bacteria Price (2013-2018)
10.6 Insects Cell Culture Sales Growth and Price
10.6.1 Global Insects Cell Culture Sales Growth (2013-2018)
10.6.2 Global Insects Cell Culture Price (2013-2018)
10.7 Transgenics Sales Growth and Price
10.7.1 Global Transgenics Sales Growth (2013-2018)
10.7.2 Global Transgenics Price (2013-2018)
11 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2013-2018)
11.2 Rheumatoid Arthritis Sales Growth (2013-2018)
11.3 Anemia Sales Growth (2013-2018)
11.4 Cancer Sales Growth (2013-2018)
11.5 Diabetes Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 BIOLOGIC THERAPEUTICS DRUGS MARKET FORECAST (2018-2023)
12.1 Global Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Biologic Therapeutics Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.2 Europe Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.4 South America Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.3 Biologic Therapeutics Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Biologic Therapeutics Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Biologic Therapeutics Drugs Market Share Forecast by Type (2018-2023)
12.4 Biologic Therapeutics Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Biologic Therapeutics Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Biologic Therapeutics Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Biologic Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Humans
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Market Analysis by Applications
1.3.1 Rheumatoid Arthritis
1.3.2 Anemia
1.3.3 Cancer
1.3.4 Diabetes
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Biologic Therapeutics Drugs Product Introduction
2.1.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biologic Therapeutics Drugs Product Information
2.1.3 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Biologic Therapeutics Drugs Market Share in 2017
2.2 AstraZeneca
2.2.1 Business Overview
2.2.1.1 AstraZeneca Description
2.2.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.2.2 AstraZeneca Biologic Therapeutics Drugs Product Introduction
2.2.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biologic Therapeutics Drugs Product Information
2.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global AstraZeneca Biologic Therapeutics Drugs Market Share in 2017
2.3 Novartis
2.3.1 Business Overview
2.3.1.1 Novartis Description
2.3.1.2 Novartis Headquarter, Main Business and Finance Overview
2.3.2 Novartis Biologic Therapeutics Drugs Product Introduction
2.3.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Biologic Therapeutics Drugs Product Information
2.3.3 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Novartis Biologic Therapeutics Drugs Market Share in 2017
2.4 Merck
2.4.1 Business Overview
2.4.1.1 Merck Description
2.4.1.2 Merck Headquarter, Main Business and Finance Overview
2.4.2 Merck Biologic Therapeutics Drugs Product Introduction
2.4.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Biologic Therapeutics Drugs Product Information
2.4.3 Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Merck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Merck Biologic Therapeutics Drugs Market Share in 2017
2.5 Smith Medical
2.5.1 Business Overview
2.5.1.1 Smith Medical Description
2.5.1.2 Smith Medical Headquarter, Main Business and Finance Overview
2.5.2 Smith Medical Biologic Therapeutics Drugs Product Introduction
2.5.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Biologic Therapeutics Drugs Product Information
2.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Smith Medical Biologic Therapeutics Drugs Market Share in 2017
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.1.1 GlaxoSmithKline Description
2.6.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.6.2 GlaxoSmithKline Biologic Therapeutics Drugs Product Introduction
2.6.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Biologic Therapeutics Drugs Product Information
2.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global GlaxoSmithKline Biologic Therapeutics Drugs Market Share in 2017
2.7 Concord Biotech
2.7.1 Business Overview
2.7.1.1 Concord Biotech Description
2.7.1.2 Concord Biotech Headquarter, Main Business and Finance Overview
2.7.2 Concord Biotech Biologic Therapeutics Drugs Product Introduction
2.7.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Biologic Therapeutics Drugs Product Information
2.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Concord Biotech Biologic Therapeutics Drugs Market Share in 2017
2.8 Aurobindo Pharma
2.8.1 Business Overview
2.8.1.1 Aurobindo Pharma Description
2.8.1.2 Aurobindo Pharma Headquarter, Main Business and Finance Overview
2.8.2 Aurobindo Pharma Biologic Therapeutics Drugs Product Introduction
2.8.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Biologic Therapeutics Drugs Product Information
2.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Aurobindo Pharma Biologic Therapeutics Drugs Market Share in 2017
2.9 H. Lundbeck
2.9.1 Business Overview
2.9.1.1 H. Lundbeck Description
2.9.1.2 H. Lundbeck Headquarter, Main Business and Finance Overview
2.9.2 H. Lundbeck Biologic Therapeutics Drugs Product Introduction
2.9.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Biologic Therapeutics Drugs Product Information
2.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global H. Lundbeck Biologic Therapeutics Drugs Market Share in 2017
2.10 Retractable Technologies
2.10.1 Business Overview
2.10.1.1 Retractable Technologies Description
2.10.1.2 Retractable Technologies Headquarter, Main Business and Finance Overview
2.10.2 Retractable Technologies Biologic Therapeutics Drugs Product Introduction
2.10.2.1 Biologic Therapeutics Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Biologic Therapeutics Drugs Product Information
2.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Retractable Technologies Biologic Therapeutics Drugs Market Share in 2017
3 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Biologic Therapeutics Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Biologic Therapeutics Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Biologic Therapeutics Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Biologic Therapeutics Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET ANALYSIS BY REGIONS
4.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Biologic Therapeutics Drugs Sales by Regions (2013-2018)
4.1.2 Global Biologic Therapeutics Drugs Revenue by Regions (2013-2018)
4.2 North America Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Biologic Therapeutics Drugs Sales by Countries (2013-2018)
5.1.2 North America Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
5.1.3 United States Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
5.2 North America Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
6 EUROPE BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologic Therapeutics Drugs Sales by Countries (2013-2018)
6.1.2 Europe Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologic Therapeutics Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
7.1.3 China Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Biologic Therapeutics Drugs Sales by Countries (2013-2018)
8.1.2 South America Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
8.2 South America Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA BIOLOGIC THERAPEUTICS DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Biologic Therapeutics Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Biologic Therapeutics Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Biologic Therapeutics Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Biologic Therapeutics Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Biologic Therapeutics Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Biologic Therapeutics Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Biologic Therapeutics Drugs Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET SEGMENT BY TYPE
10.1 Global Biologic Therapeutics Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biologic Therapeutics Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Biologic Therapeutics Drugs Revenue and Market Share by Type (2013-2018)
10.2 Humans Sales Growth and Price
10.2.1 Global Humans Sales Growth (2013-2018)
10.2.2 Global Humans Price (2013-2018)
10.3 Avian Cell Culture Sales Growth and Price
10.3.1 Global Avian Cell Culture Sales Growth (2013-2018)
10.3.2 Global Avian Cell Culture Price (2013-2018)
10.4 Yeast Sales Growth and Price
10.4.1 Global Yeast Sales Growth (2013-2018)
10.4.2 Global Yeast Price (2013-2018)
10.5 Bacteria Sales Growth and Price
10.5.1 Global Bacteria Sales Growth (2013-2018)
10.5.2 Global Bacteria Price (2013-2018)
10.6 Insects Cell Culture Sales Growth and Price
10.6.1 Global Insects Cell Culture Sales Growth (2013-2018)
10.6.2 Global Insects Cell Culture Price (2013-2018)
10.7 Transgenics Sales Growth and Price
10.7.1 Global Transgenics Sales Growth (2013-2018)
10.7.2 Global Transgenics Price (2013-2018)
11 GLOBAL BIOLOGIC THERAPEUTICS DRUGS MARKET SEGMENT BY APPLICATION
11.1 Global Biologic Therapeutics Drugs Sales Market Share by Application (2013-2018)
11.2 Rheumatoid Arthritis Sales Growth (2013-2018)
11.3 Anemia Sales Growth (2013-2018)
11.4 Cancer Sales Growth (2013-2018)
11.5 Diabetes Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 BIOLOGIC THERAPEUTICS DRUGS MARKET FORECAST (2018-2023)
12.1 Global Biologic Therapeutics Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Biologic Therapeutics Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.2 Europe Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.4 South America Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biologic Therapeutics Drugs Market Forecast (2018-2023)
12.3 Biologic Therapeutics Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Biologic Therapeutics Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Biologic Therapeutics Drugs Market Share Forecast by Type (2018-2023)
12.4 Biologic Therapeutics Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Biologic Therapeutics Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Biologic Therapeutics Drugs Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Biologic Therapeutics Drugs Picture
Table Product Specifications of Biologic Therapeutics Drugs
Figure Global Biologic Therapeutics Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-20
Figure Biologic Therapeutics Drugs Picture
Table Product Specifications of Biologic Therapeutics Drugs
Figure Global Biologic Therapeutics Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-20
